Offers advanced testing, and information in a very small package.

Insulin Buttons: This new-fangled gadget is a Russian invention from designers Vladislav Kropachev and Vladimir Makarov. It won a 2005 Design Innovation Award. What you do with it is place it on your skin and simply push down with your finger. This pierces a capsule inside the Syringe-button containing a …

Non-Invasive GlucoTrack™ Monitor Integrity Applications has developed a noninvasive glucometer that "combines three independent technologies that are operated simultaneously to provide an accurate and reliable on-the-spot reading of glucose levels in the blood. The technologies include ultrasound, conductivity, and heat capacity." The measurements’ results are analyzed by a particular algorithm, …

Accu-Chek Plus Preloaded drum of 17 strips-for no individual strip handling • No coding-for fewer steps in testing • Detachable lancet device • 300-value memory with time and date • 7-, 14-, and 30-day averages • high and low test results over 7-, 14- or 30-days Test results appear in …

This Weeks Cartoon by Theresa L. Garnero, ARNP, CDE. Issue 314

The prevalence of diagnosed diabetes in U.S. adults age 20 and older has risen from about 5.1% to 6.5%, according to researchers at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

Office and ambulatory blood pressure are independently associated with albuminuria in older patients with type 2 diabetes.

In postmenopausal women undergoing coronary angiography for suspected myocardial ischemia, past oral contraceptive use is tied to less atherosclerotic disease, according to a new study.

Findings from a new study suggest that metabolic syndrome is a risk factor for the development of heart failure, independent of known risk factors for the condition, such as interim MI.

Lipid-lowering drug treatment significantly reduced the risk of major coronary events in patients with and without type 2 diabetes, and that patients with diabetes derived more benefit from lipid-lowering therapy as primary and secondary prevention.